John A. Hovanesian, MD, FACS, focuses his blog on real-world comanagement cases with valuable take-home messages. Dr. Hovanesian is a specialist in cornea, external ocular disease and refractive and cataract surgery with Harvard Eye Associates in Laguna Hills, Calif., a clinical instructor at UCLA Jules Stein Eye Institute and a member of the Primary Care Optometry News Editorial Board.

BLOG: Patients find significant relief with microblepharoexfoliation

June 2, 2017

Advances in dry eye are coming at a furious pace, with new diagnostics and new therapeutic agents addressing a condition whose importance has recently been elevated…

BLOG: Apply three questions to any medical innovation

May 17, 2017

Our profession may be particularly receptive to innovation because those who enter eye care are self-selected for being open to new ways of thinking. We embarked on our…

BLOG: Acquisitions bring new investment, enthusiasm

April 19, 2017

The announcement that Johnson & Johnson acquired Abbott Medical Optics for just more than $4 billion was the latest in a series of acquisitions and sales of surgical…

BLOG: A case for peribulbar block

March 20, 2017

If we were to describe an ideal anesthetic agent for eye surgery, it would be one that works for virtually every patient, carries few local risks, provides deep…

BLOG: Millennial doctors offer valuable assets

February 28, 2017

There probably has never been a generation that, in middle age, didn’t look with some judgment on the group following in its footsteps. So it’s not…

BLOG: When costly drugs are standard of care

February 10, 2017

Let’s say you’re going to the hardware store to buy a wrench. Naturally, the store sells more than one product that can do the same job, but let’s…

BLOG: Going green in the surgical suite

January 23, 2017

In my operating room, we often joke that we are “going green” on those happy occasions when we don’t need to open a product that we thought we’d…

BLOG: Endophthalmitis vs. FDA audit

December 15, 2016

There’s mounting evidence that intracameral antibiotics protect the eye from endophthalmitis even better than topical therapy. The ESCRS data and a large study…

BLOG: Injections for corneal disease under study

October 7, 2016

A few years ago, retina specialists dramatically changed their approach to the treatment of exudative maculopathy by using injections that suppress just the offending…

BLOG: Sustained drug delivery will benefit the ocular surface

September 7, 2016

Delivering drugs slowly to the eye has many benefits, including increased compliance, doctor control of the type of drug used and avoidance of pressure spikes in the…

Advertisement
Advertisement